| Intertumoral heterogeneity within medulloblastoma subgroups FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ... Cancer cell 31 (6), 737-754. e6, 2017 | 888 | 2017 |
| Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas A Lassaletta, M Zapotocky, M Mistry, V Ramaswamy, M Honnorat, ... Journal of Clinical Oncology 35 (25), 2934, 2017 | 252 | 2017 |
| Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas S Ryall, M Zapotocky, K Fukuoka, L Nobre, AG Stucklin, J Bennett, ... Cancer cell 37 (4), 569-583. e5, 2020 | 215 | 2020 |
| Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas AS Guerreiro Stucklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, ... Nature Communications 10 (1), 4343, 2019 | 196 | 2019 |
| A hematogenous route for medulloblastoma leptomeningeal metastases L Garzia, N Kijima, AS Morrissy, P De Antonellis, A Guerreiro-Stucklin, ... Cell 172 (5), 1050-1062. e14, 2018 | 109 | 2018 |
| Clinical impact of additional cytogenetic aberrations, cKIT and RAS mutations, and treatment elements in pediatric t (8; 21)-AML: results from an international retrospective … K Klein, G Kaspers, CJ Harrison, HB Beverloo, A Reedijk, M Bongers, ... Journal of Clinical Oncology 33 (36), 4247, 2015 | 96 | 2015 |
| Heterogeneity within the PF-EPN-B ependymoma subgroup FMG Cavalli, JM Hübner, T Sharma, B Luu, M Sill, M Zapotocky, SC Mack, ... Acta neuropathologica 136, 227-237, 2018 | 89 | 2018 |
| ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia J Zuna, J Madzo, O Krejci, Z Zemanova, M Kalinova, K Muzikova, ... Blood, The Journal of the American Society of Hematology 117 (1), 368-369, 2011 | 81 | 2011 |
| Histone H3. 3G34-mutant interneuron progenitors co-opt PDGFRA for gliomagenesis CCL Chen, S Deshmukh, S Jessa, D Hadjadj, V Lisi, AF Andrade, D Faury, ... Cell 183 (6), 1617-1633. e22, 2020 | 79 | 2020 |
| Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience A Lassaletta, D Strother, N Laperriere, J Hukin, MI Vanan, K Goddard, ... Pediatric Blood & Cancer 65 (6), e26988, 2018 | 68 | 2018 |
| A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR P Sievers, M Sill, D Schrimpf, D Stichel, DE Reuss, D Sturm, J Hench, ... Neuro-oncology 23 (1), 34-43, 2021 | 67 | 2021 |
| Pediatric brain tumor genetics: what radiologists need to know J AlRayahi, M Zapotocky, V Ramaswamy, P Hanagandi, H Branson, ... Radiographics 38 (7), 2102-2122, 2018 | 67 | 2018 |
| Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition L Nobre, M Zapotocky, V Ramaswamy, S Ryall, J Bennett, D Alderete, ... JCO precision oncology 4, 561-571, 2020 | 62 | 2020 |
| Profound clinical and radiological response to BRAF inhibition in a 2‐month‐old diencephalic child with hypothalamic/chiasmatic glioma A Lassaletta, A Guerreiro Stucklin, V Ramaswamy, M Zapotocky, ... Pediatric blood & cancer 63 (11), 2038-2041, 2016 | 62 | 2016 |
| Differential patterns of metastatic dissemination across medulloblastoma subgroups M Zapotocky, D Mata-Mbemba, D Sumerauer, P Liby, A Lassaletta, ... Journal of Neurosurgery: Pediatrics 21 (2), 145-152, 2017 | 57 | 2017 |
| Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: cure at a cost M Zapotocky, K Beera, J Adamski, N Laperierre, S Guger, L Janzen, ... Cancer 125 (11), 1867-1876, 2019 | 53 | 2019 |
| H3 K27M mutations are extremely rare in posterior fossa group A ependymoma S Ryall, M Guzman, SK Elbabaa, B Luu, SC Mack, M Zapotocky, ... Child's Nervous System 33, 1047-1051, 2017 | 46 | 2017 |
| Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma DS Tsang, L Murray, V Ramaswamy, M Zapotocky, U Tabori, U Bartels, ... Neuro-oncology 21 (4), 547-557, 2019 | 45 | 2019 |
| Long-term visual outcomes of craniopharyngioma in children MJ Wan, M Zapotocky, E Bouffet, U Bartels, AV Kulkarni, JM Drake Journal of neuro-oncology 137, 645-651, 2018 | 45 | 2018 |
| Clinical outcomes and patient-matched molecular composition of relapsed medulloblastoma R Kumar, KS Smith, M Deng, C Terhune, GW Robinson, BA Orr, APY Liu, ... Journal of Clinical Oncology 39 (7), 807, 2021 | 39 | 2021 |
